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Primary amyloidosis localized in the urinary bladder is comparatively rare, and 40% of the patients
complain of lower urinary tract symptoms (LUTS). Although standard management for amyloidosis
localized in the urinary bladder is not established, transurethral resection (TUR) is performed in most of the
cases to diagnose the disease and to control bleeding. TUR is not considered as radical therapy for
amyloidosis localized in the urinary bladder because of frequent recurrence. Dimethyl sulfoxide (DMSO)
administered through intravenous, percutaneous or intravesical route has been shown to be effective for
treating and preventing recurrence of the disease, but its effect on LUTS due to amyloidosis localized in the
urinary bladder has not been demonstrated. We report a case showing improvement of LUTS and in which
recurrence of amyloidosis localized in the urinary bladder was prevented for 18 months by intravesical
DMSO therapy.
(Hinyokika Kiyo 59 : 453-456, 2013)





ルを目的に transurethral resection (TUR) が施行され




















入院時検査所見 : CRP 0.21 mg/dl と軽微の上昇を
認めるが，その他血液生化学検査上，特記すべき所見
なく，尿沈渣にて WBC 5∼9/HPF，RBC ＞100/HPF























Fig. 1. (A) There was wall thickness around the
trigon of the bladder on contrast-enhanced
CT and MRI before undergoing first treat-
ment with TUR. (B) Bladder wall thickness
especially at the trigon is revealed on MRI at
the first DMSO intravesical therapy after 3
total TUR procedures. (C) Findings show
















Fig. 2. (A) Shows TUR findings on cystoscopy
before therapy which shows bladder wall
thickness occupying the trigon and the blad-
der neck. (B) and (C) show cystoscopic
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Fig. 3. Histopathological findings of AA type amy-



















Fig. 4. Improvement by DMSO intravesical ther-
apy for lower urinary tract symptoms evalu-
ated by overactive bladder symptoms score
(OABSS). OABSS is a domestic interview
sheet which still requires international vali-
dation but is commonly used in Japan to
screen patients with or without OAB and to
evaluate symptomatic improvement by
treatments. A total score of over 12 points
indicates severe symptoms and a score under
5 points indicates mild symptoms.
下部尿路症状の改善を認めた (Fig. 4）．12カ月経過し
た時点で塩酸タムスロシンおよびスリフェナシンを中
























































在し，近年，間質性膀胱炎 (interstitial cystitis : IC) の
下部尿路症状に DSMO が61％奏功し9)，IC 患者の膀
胱容量を増加させた10)など炎症と下部尿路症状の改
善効果の報告があり，IC の治療の first lineと する報
告もみられる11)．しかしながら，限局性膀胱アミロ
イドーシスに対する DMSO の膀胱内注入療法が，
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